(MENAFN- PR Newswire) DUBLIN, July 3, 2023 /PRNewswire/ -- The
"molecular diagnostics: global strategic business report" report has been added to
ResearchAndMarkets.com's offering.
The global market for Molecular Diagnostics estimated at US$13.6 Billion in the year 2022, is projected to reach a revised size of US$27 Billion by 2030, growing at a CAGR of 9% over the analysis period 2022-2030.
Reagents & Kits, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$16 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 8.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $5.8 Billion, While China is Forecast to Grow at 10.3% CAGR
The Molecular Diagnostics market in the U.S. is estimated at US$5.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.6 Billion by the year 2030.
Select Competitors (Total 84 Featured) -
Abbott Laboratories Abbott Molecular Becton, Dickinson and Company bioMerieux SA Cepheid F. Hoffmann-La Roche Ltd. Grifols International, S.A. Hologic, Inc. QIAGEN N.V. QuestDiagnostics, Inc. Siemens Healthcare GmbH Tecan Group Ltd. The ELITechGroup Thermo Fisher Scientific
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As on August 27, 2020 Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests RT-PCR Emerges as the Frontline Technology for Testing COVID-19 Performance Analysis of COVID-19 Tests Need of the Hour: RT-PCR Shortages to be Tackled Effectively by Molecular Diagnostics Companies Molecular Diagnostic Companies Re-strategize Logistics to Stay at the Top End of the Game Select Tests Introduced for COVID-19 COVID-19 Plunges Fortunes of Non- COVID Diagnostics Cancer Testing Dives During First Half of 2020 Myeloproliferative Neoplasm Tests Suffer the Brunt of CoVID-19 Curbs Labs Embark New Journeys to Retain Overall Volumes Influencer Market Insights World Market Trajectories Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E) Molecular Diagnostics Competitor Market Share Scenario Worldwide (in %): 2020E Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) PCR (Technology) Global Competitor Market Share Positioning for 2020 & 2027 In-Situ Hybridization (Technology) Market Share Breakdown of Key Players: 2020 & 2027 Isothermal Amplification (Technology) Competitor Revenue Share (in %): 2020 & 2027 Sequencing (Technology) Market Share Shift by Company: 2020 & 2027 Chips & Microarrays (Technology) Global Competitor Market Share Positioning for 2020 & 2027 Reagents & Kits (Component) Market Share Breakdown of Key Players: 2020 & 2027 Instruments (Component) Competitor Revenue Share (in %): 2020 & 2027 Software & Service (Component) Market Share Shift by Company: 2020 & 2027 Molecular Diagnostics: An Introduction Types of Molecular Diagnostics Tests Market Outlook Major Growth Drivers Developing Countries Offer Strong Growth Prospects PCR Technology Leads the MDx Market Infectious Diseases: The Largest Application Market Reagents and Kits Dominate the Molecular Diagnostics Market Competition Global Molecular Diagnostics Market by Leading Player (2019) Global Molecular Diagnostics Market for Clostridium difficile by Leading Player: 2019 Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Faster Screening Necessitates Point-of-Care Diagnostics for COVID-19 Molecular Diagnostics Market Eyes Transformational Impact of Proactive Diagnostics Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19 Isothermal Amplification: An Alternative to RT-PCR for COVID-19 Testing Technological Innovations Set to Drive Market Growth New Product Developments Digitalization Trends Benefit Growth Growing Role of Molecular Diagnostics in Personalized Medicine Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 Companion Diagnostics Drive Personalized Medicine Biomarkers as Companion Diagnostics Oncology-Based Molecular Diagnostics Lead Growth Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018 Number of New Cancer Cases and Deaths (in Million) by Region for 2018 New Applications Hold Promising Potential Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum Rising Emphasis on Lab Automation to Augur Well for Market Growth World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026 Nanotechnology for Molecular Diagnostics Growing Popularity of Chemo-Sensitivity Testing of CTCs Genetic Disease Testing Offers Bright Prospects Genetic Testing to Aid in Personalized Medicine Pharmacogenomics Development Augurs Growth of Genetic Testing Market Non-Invasive Prenatal Diagnostics - The Way Ahead Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance Growing Incidence of Infectious Diseases Spurs Opportunities Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %) PCR Plays a Vital Role in the Diagnosis of Infectious Diseases Rising Incidence of Hospital Acquired Infections Propels Market Growth Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018 Number of AIDS-Related Deaths (in Thousands) by Region for 2018 Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease Home HIV Testing Emerges as a Lucrative Option Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing Hepatitis B prevalence Worldwide by Region HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market HPV Associated Disorders Market by Indication: 2019 Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing Number of New Cervix Uteri Cases in the World by Region (2018) Molecular based Tests Ingrain Roots in Blood Donor Screening Segment Rise in Healthcare Expenditure to Drive Growth World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 Aging Population Drives Molecular Diagnostics Market Elderly Healthcare Expenditure as a % of GDP Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo:
SOURCE Research and Markets
Comments
No comment